S100A8 and neoplasm: Likely released by infiltrating polymorphonuclear leukocytes, macrophages [13, 14], and by epithelial cells, extracellular S100A8/A9 in the tumor microenvironment is associated with inflammation-induced tumor progression [15] and may serve as a prognostic marker in some types of cancer [16, 17].